MARKET WIRE NEWS

AIM ImmunoTech Inc. (AIM) Q4 2024 Earnings Call Transcript

Source: SeekingAlpha

2025-04-01 09:19:30 ET

AIM ImmunoTech Inc. (AIM)

Q4 2024 Earnings Conference Call

April 01, 2025, 8:30 AM ET

Company Participants

Thomas Equels - Chief Executive Officer, President and Executive Vice Chairman

Conference Call Participants

Ed Woo - Ascendiant Capital Markets

Presentation

Operator

Hello and welcome to the AIM ImmunoTech Fourth Quarter and Full Year 2024 Update Conference Call and Webcast. As a brief reminder, all participants are currently in a listen-only mode. [Operator Instructions] Following the presentation, there will be a question-and-answer session. Note that this webcast is being recorded at the company's request and a replay will be made available on the company's website following the end of the event.

At this time, I'd like to remind our listeners that remarks made during the webcast may state management's intentions, beliefs, expectations, or future projections. These are forward-looking statements that involve risks and uncertainties. Forward-looking statements on this call are made pursuant to the Safe Harbor provisions of the federal securities laws and are based on AIM ImmunoTech's current expectations and actual results could differ materially....

Read the full article on Seeking Alpha

For further details see:

AIM ImmunoTech Inc. (AIM) Q4 2024 Earnings Call Transcript
AIM ImmunoTech Inc.

NASDAQ: AIM

AIM Trading

-8.92% G/L:

$0.3678 Last:

9,694,908 Volume:

$0.3666 Open:

VWAV Ad 300

AIM Latest News

May 14, 2026 05:00:00 pm
AIMIA CONFIRMS ELECTION OF DIRECTORS

AIM Stock Data

$3,240,384
3,276,294
0.11%
8
N/A
Biotechnology & Life Sciences
Healthcare
US
Ocala

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App